217 related articles for article (PubMed ID: 32001383)
1. Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients.
Chen WC; Baal JD; Baal U; Pai J; Gottschalk A; Boreta L; Braunstein SE; Raleigh DR
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):48-61. PubMed ID: 32001383
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
[TBL] [Abstract][Full Text] [Related]
4. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
[TBL] [Abstract][Full Text] [Related]
7. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Klement RJ; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2021 Jul; 149(2):358-370. PubMed ID: 33682927
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China.
Zhao X; Zhu X; Zhuang H; Guo X; Song Y; Ju X; Wang P; Yuan Z; Zhang H
Sci Rep; 2020 May; 10(1):7836. PubMed ID: 32398700
[TBL] [Abstract][Full Text] [Related]
10. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis.
Yu T; Shin IS; Yoon WS; Rim CH
Clin Lung Cancer; 2019 Jul; 20(4):e452-e462. PubMed ID: 31029573
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Stereotactic Body Radiation Therapy for Pediatric Malignancies: The LITE-SABR Systematic Review and Meta-Analysis.
Singh R; Valluri A; Didwania P; Lehrer EJ; Baliga S; Hiniker S; Braunstein SE; Murphy ES; Lazarev S; Tinkle C; Terezakis S; Palmer JD
Adv Radiat Oncol; 2023; 8(2):101123. PubMed ID: 36845622
[TBL] [Abstract][Full Text] [Related]
13. Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors.
Stumpf PK; Yorke ED; El Naqa I; Cuneo KC; Grimm J; Goodman KA
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):217-226. PubMed ID: 33864824
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
Franzese C; Stefanini S; Massaro M; Comito T; Navarria P; Clerici E; Teriaca A; Franceschini D; Reggiori G; Tomatis S; Lania A; Scorsetti M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3619-3625. PubMed ID: 34537907
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis.
Liao X; Kishi K; Du K; Komaki R; Mizoe J; Aikawa G; Zheng W; Pan C
Front Oncol; 2023; 13():1193574. PubMed ID: 38045003
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Yan M; Louie AV; Kotecha R; Ashfaq Ahmed M; Zhang Z; Guckenberger M; Kim MS; Lo SS; Scorsetti M; Tree AC; Sahgal A; Slotman BJ
Lung Cancer; 2023 Aug; 182():107281. PubMed ID: 37393758
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Radiotherapy for Adrenal Metastases: A Multi-Institutional Review of Patient Characteristics and Outcomes - Turkish Society for Radiation Oncology SBRT Group Study (Trod SBRT 10-004).
Elmali A; Akkus Yildirim B; Cengiz M; Yuce Sari S; Onal HC; Berber T; Arslantas Erken A; Zoto Mustafayev T; Atalar B; Unal I; Kaydihan N; Oner Dincbas F
Oncol Res Treat; 2022; 45(12):717-727. PubMed ID: 36116432
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
Chance WW; Nguyen QN; Mehran R; Welsh JW; Gomez DR; Balter P; Komaki R; Liao Z; Chang JY
Pract Radiat Oncol; 2017; 7(3):e195-e203. PubMed ID: 27743801
[TBL] [Abstract][Full Text] [Related]
19. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis.
Zaorsky NG; Lehrer EJ; Handorf E; Meyer JE
Am J Clin Oncol; 2019 Jan; 42(1):46-55. PubMed ID: 29965809
[TBL] [Abstract][Full Text] [Related]
20. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Rim CH; Kim HJ; Seong J
Radiother Oncol; 2019 Feb; 131():135-144. PubMed ID: 30773180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
